AMD Faces Losses as U.S. Tightens Chip Export Restrictions to China

AMD braces for significant financial charges after new U.S. rules hit advanced chip exports to China, one of its largest markets, impacting its next-gen Artificial Intelligence processors.

AMD has disclosed that it expects to incur substantial financial charges following the latest decision by the U.S. government to further restrict exports of cutting-edge processors to China. The affected products include AMD´s MI308 accelerator chips, designed for high-performance computing, including Artificial Intelligence workloads. The new regulatory requirements, announced by the U.S. Commerce Department, will necessitate special licenses for shipping advanced chips such as AMD’s MI308 and NVIDIA’s H20 to China—licenses that historically have not been granted for these types of products.

China is a critical market for AMD, representing its second-largest revenue stream in 2024, accounting for over 24% of the company´s total annual sales. Despite the company’s anticipation of applying for export licenses, AMD´s regulatory filings acknowledge the possible charges tied to inventory write-downs, unfulfilled purchase commitments, and additional reserve requirements. The company also warns of significant uncertainty around the likelihood of gaining the necessary export licenses, referencing analysis from Jefferies that highlights the U.S. government’s longstanding reluctance to approve such applications related to high-performance graphics processors.

The impact of the U.S. export crackdown is reverberating across the semiconductor industry. News of the restrictions closely follows NVIDIA´s separate announcement anticipating more than half a billion dollars in related charges for its own high-end chips intended for China. In the hours after the announcements, AMD and NVIDIA both saw their stock prices drop by more than 5 percent, reflecting investor concern over the future of the companies’ business in the world’s second-largest economy and intensifying regulatory headwinds for advanced processor technology exports.

77

Impact Score

Nvidia and Abridge build clinical Artificial Intelligence model

Nvidia is partnering with Abridge on a healthcare-focused Artificial Intelligence model designed for real doctor-patient conversations. The system will run inside Abridge’s clinical scribe platform, which is already used by major health systems.

Artificial Intelligence shifts into execution and scrutiny

London Tech Week focused on responsible Artificial Intelligence deployment as companies, regulators and investors moved from ambition to implementation. OpenAI’s IPO plans, Meta’s WhatsApp dispute, drone defence partnerships and changing junior roles defined the week’s technology agenda.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.